Research Article
Assessment of Trimetazidine Treatment in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention
Table 1
Baseline clinical characteristics.
| | Indices | TMZ group (n = 200) | Control group (n = 201) | value |
| | Age (years) | 64.3 ± 11.3 | 64.2 ± 10.9 | 0.877 | | Male sex (%) | 143 (72) | 146 (73) | 0.800 | | Hypertension (%) | 95 (48) | 103 (51) | 0.453 | | Diabetes (%) | 89 (45) | 84 (42) | 0.584 | | Dyslipidemia(%) | 87 (44) | 72 (36) | 0.116 | | Smoker (%) | 113 (57) | 126 (63) | 0.207 | | Prior MI (%) | 25 (13) | 16 (8) | 0.134 | | Angina pectoris (%) | 104 (52) | 109 (54) | 0.655 | | Peripheral arterial disease (%) | 13 (7) | 17 (8) | 0.456 | | Atrial fibrillation/flutter | 10 (5) | 15 (7) | 0.308 | | Prior stroke/TIA (%) | 30 (15) | 32 (16) | 0.799 | | Killip (%) | | 1 | 108 (54) | 103 (51) | 0.580 | | 2 | 77 (39) | 78 (39) | 0.950 | | 3 | 15 (8) | 20 (10) | 0.385 | | Culprit lesion (%) | | LAD | 102 (51) | 116 (58) | 0.177 | | LCX | 44 (22) | 36 (18) | 0.306 | | RCA | 54 (27) | 49 (24) | 0.548 | | Number of stents | 1.2 ± 0.4 | 1.2 ± 0.4 | 0.691 | | PPCI | 145 (73) | 135 (67) | 0.244 | | TIMI grade 0-2 before PCI (%) | 144 (72) | 133 (66) | 0.207 | | Manual thrombus aspiration (%) | 17 (9) | 19 (9) | 0.739 |
|
|
MI, myocardial infarction; TIA, transient ischemic attack; PPCI, primary percutaneous coronary intervention; TIMI, thrombolysis in myocardial infarction.
|
